Fast Track Initiative (FTI) is a healthcare-focused venture capital firm that operates in Japan and the US. With over 18 years of investment experience and a total of $200M AUM, we have become a pioneer of healthcare venture investments in Japan, focusing our investments on early-stage life science startups. We invest in and grow seed and early-stage companies across a broad range of healthcare sectors including therapeutics, diagnostics, digital health, and healthcare services, with a strong focus on therapeutic platforms. 

We provide hands-on operational support to our 30+ portfolio companies through business and R&D Strategy, strategic partnership, investor syndication, and management recruitment, as well as scouting crude technologies from academia while using our exclusive network of leading industry professionals in the country.

Japan has long been a global source of innovation and technology, particularly in the field of wellness and health innovation, cultivating life-changing medicine. Due to their robust academic and research infrastructure, the number of biotech companies has increased significantly over the years along with interest from venture capital on a global level.

We distinguish ourselves amongst others with decades of experience and connections with our network of academia, corporates, regulators, and investors in Japan. With significant resources in the region, we aim to use our global expertise to help healthcare startups achieve innovation internationally from a stronger, unique perspective.

Fast Track Initiative

Org chart

Teams

Offices